E. Vannier

发表

Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis: correlations with markers of inflammation and joint destruction.

C. Dinarello, P. Miossec, P. Jouvenne, 1998, Arthritis and rheumatism.

Dermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signaling

Jun Yao, D. Carrasco, A. Camargo, 2015, BMC Cancer.

Imbalance between interleukin‐1 agonists and antagonists: relationship to severity of inflammatory bowel disease

H. Tilg, I. Borggraefe, E. Vannier, 2004, Clinical and Experimental Immunology.

Impaired counter-regulation of interleukin-1 by the soluble IL-1 receptor type II in patients with chronic liver disease

H. Tilg, A. Kaser, A. Moschen, 2008, Scandinavian journal of gastroenterology.

Effects of resistance exercise combined with essential amino acid supplementation and energy deficit on markers of skeletal muscle atrophy and regeneration during bed rest and active recovery

R. Roubenoff, K. Myburgh, G. Cloutier, 2010, Muscle & nerve.

Babesia microti Primarily Invades Mature Erythrocytes in Mice

A. Spielman, I. Borggraefe, Sohela Shah, 2006, Infection and Immunity.

Suppression of juvenile chronic myelogenous leukemia colony growth by interleukin-1 receptor antagonist.

M. Arsura, G. Masera, C. Dinarello, 1994, Blood.

Balance of IL-1 receptor antagonist/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10.

J. Banchereau, J. Déchanet, C. Dinarello, 1995, Journal of immunology.

R. Roubenoff, J. Blumberg, J. Cannon, 2006, American journal of physiology. Endocrinology and metabolism.

Correlation of serum levels of interleukin-1 family members with disease activity and response to treatment in hairy cell leukemia.

C. Dinarello, V. Barak, E. Vannier, 1998, European cytokine network.

Production of interleukin-1 receptor antagonist and interleukin-1 beta by peripheral blood mononuclear cells is differentially regulated.

C. Dinarello, B. D. Clark, E. Vannier, 1991, Blood.

EFFECT OF STRENGTH TRAINING ON CYTOKINE MRNA LEVELS IN SKELETAL MUSCLE OF DIABETIC HISPANIC ELDERS

C. Castaneda, J. Layne, R. Roubenoff, 2002 .

Human immunodeficiency virus does not induce interleukin-1, interleukin-6, or tumor necrosis factor in mononuclear cells

D. Scadden, J. Groopman, C. Dinarello, 1990, Journal of virology.

Histamine enhances interleukin (IL)-1-induced IL-1 gene expression and protein synthesis via H2 receptors in peripheral blood mononuclear cells. Comparison with IL-1 receptor antagonist.

C. Dinarello, E. Vannier, E. Vannier, 1993, The Journal of clinical investigation.

Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: I. IL-1 receptor antagonist inhibits IL-1-induced cytokine synthesis and blocks the binding of IL-1 to its type II receptor on human monocytes.

C. Dinarello, B. D. Clark, E. Vannier, 1992, Blood.

Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: II. IL-1 receptor antagonist inhibits lipopolysaccharide-induced cytokine synthesis by human monocytes.

C. Dinarello, E. Vannier, D. Poutsiaka, 1992, Blood.

A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses.

L. Shapiro, C. Dinarello, S. Wolff, 1995, Journal of immunology.

MyD88-Dependent Pathways Mediate Resistance to Cryptosporidium parvum Infection in Mice

S. Akira, D. Golenbock, S. Uematsu, 2006, Infection and Immunity.

Cross-linking of the beta-glucan receptor on human monocytes results in interleukin-1 receptor antagonist but not interleukin-1 production.

C. Dinarello, M. Mengozzi, E. Vannier, 1993, Blood.

IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels

P. Miossec, G. Duff, E. Vannier, 2001, Genes and Immunity.

Coinfection by the tick-borne pathogens Babesia microti and Borrelia burgdorferi : ecological, epidemiological and clinical consequences

P. Krause, M. Diuk-Wasser, E. Vannier, 2016 .

Induction of circulating IL-1 receptor antagonist by IFN treatment.

H. Tilg, J. Mier, C. Dinarello, 1993, Journal of immunology.

Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist.

C. Dinarello, E. Vannier, L. Miller, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Live Borrelia burgdorferi preferentially activate interleukin-1 beta gene expression and protein synthesis over the interleukin-1 receptor antagonist.

A. Steere, C. Dinarello, E. Vannier, 1992, The Journal of clinical investigation.

Senescence of human skeletal muscle impairs the local inflammatory cytokine response to acute eccentric exercise

R. Roubenoff, J. Sacheck, A. Witsell, 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Persistent and relapsing babesiosis in immunocompromised patients.

M. Young, S. Telford, A. Spielman, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Shared features in the pathobiology of babesiosis and malaria.

J. Daily, A. Spielman, P. Krause, 2007, Trends in parasitology.

Age-associated decline in resistance to Babesia microti is genetically determined.

A. Spielman, I. Borggraefe, J. Gelfand, 2004, The Journal of infectious diseases.

The pattern of interleukin-1beta (IL-1beta) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections.

C. Dinarello, J. V. D. van der Meer, M. van Deuren, 1997, Blood.

Modulation of cell proliferation and cytokine production in acute myeloblastic leukemia by interleukin-1 receptor antagonist and lack of its expression by leukemic cells.

T. Barbui, C. Dinarello, F. Cozzolino, 1991, Blood.

A Phase I Study of Interleukin-10 in Healthy Humans: Safety and Effects on Cytokine Production

L. Shapiro, C. Dinarello, S. Wolff, 1995 .

Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans.

J. Mier, C. Dinarello, R. Porat, 1993, Journal of immunology.

Comparison of granulocyte-macrophage colony stimulating factor and interleukin-1 production from human peripheral blood mononuclear cells as measured by specific radioimmunoassays.

M. Klempner, C. Dinarello, E. Vannier, 1992, European cytokine network.

Cutting Edge: Activation of STING in T Cells Induces Type I IFN Responses and Cell Death

M. Sorokin, A. Buzdin, A. Poltorak, 2017, The Journal of Immunology.

This information is current as Death Induces Type I IFN Responses and Cell Cutting Edge : Activation of STING in T Cells

A. Buzdin, A. Poltorak, E. Vannier, 2017 .

by peripheral blood mononuclear cells is differentially regulated Production of interleukin-1 receptor antagonist and interleukin-1 beta

C. Dinarello, B. D. Clark, E. Vannier, 2011 .

Hematologic and immunomodulatory effects of an interleukin-1 receptor antagonist coinfusion during low-dose endotoxemia in healthy humans.

J. Mier, R. Porat, K. Ye, 1993, Blood.

Interleukin-13 (IL-13) induces IL-1 receptor antagonist gene expression and protein synthesis in peripheral blood mononuclear cells: inhibition by an IL-4 mutant protein.

R. de Waal Malefyt, C. Dinarello, J. D. de Vries, 1996, Blood.

Effects of the stem cell factor, c-kit ligand, on human megakaryocytic cells.

S. Jiang, K. Zsebo, J. Groopman, 1992, Blood.

Induction of circulating antagonists to IL-1 and TNF by IL-2 administration and their effects on IL-2 induced cytokine production in vitro.

H. Tilg, M. Atkins, J. Mier, 1994, Journal of immunology.

Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors.

S. Dower, C. Dinarello, F. Cozzolino, 1996, Experimental hematology.

Three distinct promoters direct transcription of different 5' untranslated regions of the human interleukin 1 type I receptor: a possible mechanism for control of translation.

C. Dinarello, K. Ye, B. D. Clark, 1996, Cytokine.

Update on Babesiosis

P. Krause, E. Vannier, 2009, Interdisciplinary perspectives on infectious diseases.

Skeletal muscle wasting and renewal: a pivotal role of myokine IL-6

J. Belizário, E. Vannier, Cibely C. Fontes-Oliveira, 2016, SpringerPlus.

Clofazimine, a promising drug for the treatment of Babesia microti infection in severely immunocompromised hosts.

P. Krause, I. Igarashi, E. Vannier, 2020, The Journal of infectious diseases.

Cross-linking of the beta-glucan receptor on human monocytes results in interleukin-1 receptor antagonist but not interleukin-1 production

C. Dinarello, M. Mengozzi, E. Vannier, 1993 .

Coinfection by Ixodes Tick-Borne Pathogens: Ecological, Epidemiological, and Clinical Consequences.

P. Krause, M. Diuk-Wasser, E. Vannier, 2016, Trends in parasitology.

Borrelia burgdorferi Promotes the Establishment of Babesia microti in the Northeastern United States

Durland Fish, Stephen Davis, Meagan C. Fitzpatrick, 2014, PloS one.

A global map of genetic diversity in Babesia microti reveals strong population structure and identifies variants associated with clinical relapse

Pardis C. Sabeti, Stephen F. Schaffner, Jeffrey A. Bailey, 2016, Nature Microbiology.

Histamine suppresses gene expression and synthesis of tumor necrosis factor alpha via histamine H2 receptors

C. Dinarello, E. Vannier, L. Miller, 1991, The Journal of experimental medicine.

Interleukin-1β, Interleukin-1 Receptor Antagonist, and Soluble Interleukin-1 Receptor Type II Secretion in Chronic Fatigue Syndrome

A. Komaroff, J. Cannon, S. Wolff, 1997, Journal of Clinical Immunology.

Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA): 2020 Guideline on Diagnosis and Management of Babesiosis.

G. Wormser, P. Krause, J. Branda, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: A Review.

G. Wormser, E. Vannier, Linden T. Hu, 2016, JAMA.

Babesiosis in China, an emerging threat.

P. Krause, E. Vannier, 2015, The Lancet. Infectious diseases.

Transplacental Transmission of Human Babesiosis

P. Krause, E. Vannier, 2012 .

Histamine enhances interleukin (IL)-1-induced IL-6 gene expression and protein synthesis via H2 receptors in peripheral blood mononuclear cells.

C. Dinarello, E. Vannier, 1994, The Journal of biological chemistry.

Effects of the stem cell factor, c-kit ligand, on human megakaryocytic cells

K. Zsebo, J. Groopman, C. Dinarello, 1992 .

Production of Cytokines by Peripheral Blood Monocytes/Macrophages Infected with Human Immunodeficiency Virus Type I (HIV-I)

J. Groopman, C. Dinarello, E. Vannier, 1990 .

Elevated circulating levels of soluble interleukin-1 receptor type II during interleukin-2 immunotherapy.

H. Tilg, A. Kaser, M. Atkins, 1999, European cytokine network.

Genes up- and down-regulated by dermcidin in breast cancer: a microarray analysis.

J. Belizário, E. Vannier, D. Moreira, 2008, Genetics and molecular research : GMR.

Neutrophils and macrophages drive TNF-induced lethality via TRIF/CD14-mediated responses.

A. Poltorak, I. Smirnova, E. Vannier, 2022, Science immunology.

Both C3a and C3a(desArg) regulate interleukin-6 synthesis in human peripheral blood mononuclear cells.

R. Tompkins, J. Gelfand, B. D. Clark, 1998, Journal of Infectious Diseases.

Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells

H. Tilg, J. Mier, C. Dinarello, 1993, The Journal of experimental medicine.

IL-4 VNTR gene polymorphism in chronic polyarthritis. The rare allele is associated with protection against destruction.

P. Miossec, E. Vannier, M. Chabaud, 2000, Rheumatology.

its expression by leukemic cells myeloblastic leukemia by interleukin-1 receptor antagonist and lack of Modulation of cell proliferation and cytokine production in acute

T. Barbui, F. Cozzolino, M. Torcia, 2011 .

A new biologic role for C3a and C3a desArg: regulation of TNF-alpha and IL-1 beta synthesis.

C. Dinarello, J. Gelfand, B. D. Clark, 1996, Journal of immunology.

Menstrual‐ and gender‐dependent variations in circulating IL‐1 agonists, antagonists, and binding proteins

J. Cannon, E. Vannier, L. Abad, 1998, Journal of leukocyte biology.

Effects of aging and cytokine blockade on inflammatory cachexia.

R. Roubenoff, C. Edwards, E. Vannier, 2004, Clinical and experimental rheumatology.

Clinical, hematologic, and immunologic effects of interleukin-10 in humans

Edouard Vannier, L. Shapiro, C. Dinarello, 1996, Journal of Clinical Immunology.

Resistance Training Alters Cytokine Gene Expression in Skeletal Muscle of Adults with Type 2 Diabetes

J. Layne, R. Roubenoff, E. Vannier, 2006, International journal of immunopathology and pharmacology.

Suppression of juvenile chronic myelogenous leukemia colony growth by interleukin-1 receptor antagonist

M. Arsura, G. Masera, C. Dinarello, 1994 .

HIV protease inhibitors block parasite signal peptide peptidases and prevent growth of Babesia microti parasites in erythrocytes.

A. Chishti, T. Hanada, E. Vannier, 2019, Biochemical and biophysical research communications.

Broad antimicrobial resistance in a case of relapsing babesiosis successfully treated with tafenoquine.

P. Krause, Ashlyn M. Norris, E. Vannier, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome.

A. Komaroff, J. Cannon, S. Wolff, 1997, Journal of Clinical Immunology.

Cytokine gene expression and synthesis by human megakaryocytic cells.

J. Groopman, C. Dinarello, E. Vannier, 1992, International journal of cell cloning.

Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA): 2020 Guideline on Diagnosis and Management of Babesiosis.

G. Wormser, P. Krause, J. Branda, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clofazimine for babesiosis: preclinical data support a clinical trial.

J. Gelfand, E. Vannier, 2021, The Journal of infectious diseases.